Clinical Trials Directory

Trials / Completed

CompletedNCT02868320

SMS Technology for the Promotion of Diabetes Education and Self-Management in Egypt

SMS Technology for the Promotion of Diabetes Education and Self-Management

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
73 (actual)
Sponsor
Hannover Medical School · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study was conducted at the teaching hospital of Misr University for Science \& Technology. It aimed to examine the use of SMS technology in educating and monitoring diabetic patients in Egypt, and assess the impact of educational text messages on their glycemic control and self-management behaviors. Participants were randomized into an intervention and a control group. Intervention patients received an instruction booklet as well as daily educational and weekly reminder messages to better control their diabetes. Control patients received the same instruction booklet but no SMS messages. Both group patients took an HbA1c test at the beginning and end of the study period and were asked to measure their blood glucose once a week and record their readings into a monitoring table over 12 weeks. The primary outcome was the change in HbA1c levels, which was expected to be greater among intervention patients at the end of the study. Secondary outcomes included blood glucose levels, treatment and medication adherence, diabetes self-efficacy, rate of hospital/ER visits, frequency of blood glucose measurement, among others.

Conditions

Interventions

TypeNameDescription
OTHERSMS messagesDaily educational messages addressing the following categories: diet, exercise, complications, medications, foot care, blood sugar testing, and hypo- and hyperglycemia. Weekly reminder messages of blood glucose testing.
OTHERInstruction bookletGeneral detailed instructions addressing the same SMS categories.

Timeline

Start date
2014-04-01
Primary completion
2015-06-01
Completion
2015-07-01
First posted
2016-08-16
Last updated
2016-08-16

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02868320. Inclusion in this directory is not an endorsement.